Published: 06/14/2022 02:03 GMT Incyte Corp. (INCY) - :fda Approves Lilly and Incyte's Olumiant® (baricitinib) As First and Only Systemic Medicine for Adults With Severe Alopecia Areata.
Lilly Also Expects Regulatory Decisions for Olumiant in Aa in European Union and Japan in 2022.
